Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
作者信息
Graepel Kevin W, Kochhar Sonali, Clayton Ellen W, Edwards Kathryn E
机构信息
Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Global Healthcare Consulting, New Delhi, India.
出版信息
J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234.
Abstract
摘要
相似文献
1
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.在严重急性呼吸综合征冠状病毒2疫苗研发中平衡权宜性与科学严谨性
J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234.
2
Rapid COVID-19 vaccine development.新冠疫苗的快速研发。
Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb8923. Epub 2020 May 8.
3
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.詹纳和巴斯德会如何应对新冠冠状病毒？一位疫苗学家的呼吁。
Front Immunol. 2020 Aug 26;11:2173. doi: 10.3389/fimmu.2020.02173. eCollection 2020.
4
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.新闻特写：避免在研发新冠疫苗过程中陷入困境。
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221. doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.
5
Development of an inactivated vaccine candidate for SARS-CoV-2.SARS-CoV-2 灭活疫苗候选物的研发。
Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6.
6
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.2020 年大流行：当前 SARS-CoV-2 疫苗的开发。
Front Immunol. 2020 Aug 19;11:1880. doi: 10.3389/fimmu.2020.01880. eCollection 2020.
7
COVID-19 shot protects monkeys.新冠疫苗对猴子有保护作用。
Science. 2020 May 1;368(6490):456-457. doi: 10.1126/science.368.6490.456.
8
Coronavirus vaccines leap through safety trials - but which will work is anybody's guess.新冠病毒疫苗迅速通过安全性试验——但哪种疫苗会有效，谁也说不准。
Nature. 2020 Jul;583(7818):669-670. doi: 10.1038/d41586-020-02174-y.
9
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
10
SARS-CoV-2: A New Song Recalls an Old Melody.SARS-CoV-2：一首新歌唤起旧旋律。
Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.
引用本文的文献
1
Antibody-dependent enhancement of coronaviruses.冠状病毒的抗体依赖性增强作用。
Int J Biol Sci. 2025 Feb 3;21(4):1686-1704. doi: 10.7150/ijbs.96112. eCollection 2025.
2
Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals.商业干扰素-γ释放试验评估既往感染 COVID-19 与未感染者对 mRNA 疫苗第一剂和第二剂的免疫应答。
Diagn Microbiol Infect Dis. 2022 Apr;102(4):115573. doi: 10.1016/j.diagmicrobio.2021.115573. Epub 2021 Oct 10.
3
A Meta-Analysis of Rhesus Macaques (), Cynomolgus Macaques (), African green monkeys (), and Ferrets () as Large Animal Models for COVID-19.恒河猴（）、食蟹猴（）、绿猴（）和雪貂（）作为 COVID-19 大动物模型的荟萃分析。
Comp Med. 2021 Oct 1;71(5):433-441. doi: 10.30802/AALAS-CM-21-000032. Epub 2021 Sep 29.
4
[Vaccine against COVID-19].[新型冠状病毒肺炎疫苗]
Rev Esp Quimioter. 2021 Dec;34(6):559-598. doi: 10.37201/req/085.2021. Epub 2021 Jun 28.
5
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.一种灭活的严重急性呼吸综合征冠状病毒 2 型疫苗（BBV152）的安全性和免疫原性：一项双盲、随机、1 期临床试验。
Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21.
6
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.中东呼吸综合征、严重急性呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2的比较与对比：预防、传播、管理及疫苗研发
Pathogens. 2020 Nov 26;9(12):985. doi: 10.3390/pathogens9120985.
7
Case Report: Recurrent Clinical Symptoms of COVID-19 in Healthcare Professionals: A Series of Cases from Brazil.病例报告：巴西医护人员中反复出现的 COVID-19 临床症状：一系列病例。
Am J Trop Med Hyg. 2020 Nov;103(5):1993-1996. doi: 10.4269/ajtmh.20-0893.
8
COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.COVID-19 疫苗：“超速”需要心灵融合，而不是扭曲的思维。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01083-20.
本文引用的文献
1
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
2
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.人类挑战研究加速冠状病毒疫苗许可。
J Infect Dis. 2020 May 11;221(11):1752-1756. doi: 10.1093/infdis/jiaa152.
3
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.抗体依赖增强作用促进冠状病毒进入的分子机制。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.02015-19.
4
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.抗中东呼吸综合征冠状病毒 DNA 疫苗的安全性和免疫原性：一项 1 期、开放性、单臂、剂量递增试验。
Lancet Infect Dis. 2019 Sep;19(9):1013-1022. doi: 10.1016/S1473-3099(19)30266-X. Epub 2019 Jul 24.
5
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.抗刺突 IgG 通过在急性 SARS-CoV 感染期间使巨噬细胞反应发生偏斜，导致严重的急性肺损伤。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.123158.
6
From SARS to MERS, Thrusting Coronaviruses into the Spotlight.从 SARS 到 MERS，冠状病毒备受瞩目。
Viruses. 2019 Jan 14;11(1):59. doi: 10.3390/v11010059.
7
Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.严重急性呼吸综合征冠状病毒感染的抗体依赖性增强作用及其在严重急性呼吸综合征发病机制中的作用。
Hong Kong Med J. 2016 Jun;22(3 Suppl 4):25-31.
8
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.呼吸道合胞病毒增强疾病的简史与特征
Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15.
9
Evaluation of candidate vaccine approaches for MERS-CoV.中东呼吸综合征冠状病毒候选疫苗方法的评估
Nat Commun. 2015 Jul 28;6:7712. doi: 10.1038/ncomms8712.
10
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.用δ-菊粉佐剂配制的严重急性呼吸综合征相关冠状病毒疫苗在改善肺部嗜酸性粒细胞免疫病理学的同时提供了增强的保护作用。
J Virol. 2015 Mar;89(6):2995-3007. doi: 10.1128/JVI.02980-14. Epub 2014 Dec 17.
Zotero 插件